DK1267833T3 - Farmaceutiske præparater og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutiske præparater og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1267833T3
DK1267833T3 DK01917326T DK01917326T DK1267833T3 DK 1267833 T3 DK1267833 T3 DK 1267833T3 DK 01917326 T DK01917326 T DK 01917326T DK 01917326 T DK01917326 T DK 01917326T DK 1267833 T3 DK1267833 T3 DK 1267833T3
Authority
DK
Denmark
Prior art keywords
particles
processes
preparation
pharmaceutical compositions
emulsion
Prior art date
Application number
DK01917326T
Other languages
English (en)
Inventor
John Nicholas Staniforth
Michael John Tobyn
Cheryl Julia Clinch
Robert Price
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1267833(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vectura Ltd filed Critical Vectura Ltd
Application granted granted Critical
Publication of DK1267833T3 publication Critical patent/DK1267833T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Colloid Chemistry (AREA)
DK01917326T 2000-04-05 2001-04-05 Farmaceutiske præparater og fremgangsmåde til fremstilling deraf DK1267833T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008411.1A GB0008411D0 (en) 2000-04-05 2000-04-05 Pharmaceutical preparations and their manufacture

Publications (1)

Publication Number Publication Date
DK1267833T3 true DK1267833T3 (da) 2004-07-19

Family

ID=9889294

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01917326T DK1267833T3 (da) 2000-04-05 2001-04-05 Farmaceutiske præparater og fremgangsmåde til fremstilling deraf

Country Status (22)

Country Link
US (2) US20030157182A1 (da)
EP (1) EP1267833B1 (da)
JP (1) JP2003528907A (da)
KR (1) KR20030011816A (da)
CN (1) CN1420764A (da)
AT (1) ATE269057T1 (da)
AU (1) AU4440601A (da)
BR (1) BR0109802A (da)
CA (1) CA2404367A1 (da)
DE (1) DE60103865T2 (da)
DK (1) DK1267833T3 (da)
ES (1) ES2218402T3 (da)
GB (1) GB0008411D0 (da)
HU (1) HUP0300334A3 (da)
IL (1) IL152074A0 (da)
MX (1) MXPA02009797A (da)
NO (1) NO20024737L (da)
PL (1) PL357808A1 (da)
PT (1) PT1267833E (da)
TR (1) TR200401567T4 (da)
WO (1) WO2001074332A1 (da)
ZA (1) ZA200207508B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065372A1 (en) * 2003-02-21 2007-03-22 Robert Price Process for the production of particles
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
CN101272769B (zh) * 2005-07-28 2013-04-24 Isp投资有限公司 生物利用度提高的苯醌类化合物
JP2007326083A (ja) * 2006-06-09 2007-12-20 Fujifilm Corp 固体微粒子及びその製造方法
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
CN101541415B (zh) * 2006-11-14 2012-08-22 巴斯夫欧洲公司 生产亚微核/壳粒子的微悬浮乳液或悬浮液的方法
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
WO2008080037A2 (en) * 2006-12-21 2008-07-03 Isp Investments Inc. Carotenoids of enhanced bioavailability
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
JP5508859B2 (ja) * 2007-01-26 2014-06-04 アイエスピー インヴェストメンツ インコーポレイテッド 噴霧乾燥製品を製造するための調剤処理方法
PL220269B1 (pl) 2008-04-21 2015-09-30 Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego
BRPI0915783A2 (pt) * 2008-07-18 2018-05-22 Prosonix Ltd processo para aumentar a cristalinidade de pelo menos um material sólido, partícula, composição farmacêutica ou agroquímica , e, inalador
CN102107127B (zh) * 2011-01-11 2015-04-22 西安蓝晓科技新材料股份有限公司 一种粉体造粒技术
WO2013010210A1 (en) * 2011-07-15 2013-01-24 Eupharma Pty Ltd Oral compositions comprising an antacid, an anaesthetic and an inorganic matrix comprising silicon dioxide and titanium dioxide
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
JP6832950B2 (ja) * 2016-11-10 2021-02-24 日本たばこ産業株式会社 球状の粉末凝集体及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
CA2474701C (en) * 1993-11-19 2009-01-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradeable microparticles containing a biologically active agent
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
DE19617085A1 (de) * 1996-04-29 1997-10-30 Bayer Ag Verfahren zur Herstellung von feinstteiligen Kristallisationsprodukten
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6150505A (en) 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions

Also Published As

Publication number Publication date
US20030157182A1 (en) 2003-08-21
NO20024737L (no) 2002-11-18
PT1267833E (pt) 2004-11-30
AU4440601A (en) 2001-10-15
KR20030011816A (ko) 2003-02-11
BR0109802A (pt) 2003-01-21
EP1267833B1 (en) 2004-06-16
TR200401567T4 (tr) 2004-08-23
HUP0300334A3 (en) 2005-04-28
JP2003528907A (ja) 2003-09-30
DE60103865D1 (de) 2004-07-22
WO2001074332A1 (en) 2001-10-11
NO20024737D0 (no) 2002-10-02
CA2404367A1 (en) 2001-10-11
HUP0300334A2 (hu) 2003-09-29
GB0008411D0 (en) 2000-05-24
EP1267833A1 (en) 2003-01-02
CN1420764A (zh) 2003-05-28
ES2218402T3 (es) 2004-11-16
US20100015234A1 (en) 2010-01-21
IL152074A0 (en) 2003-05-29
PL357808A1 (en) 2004-07-26
MXPA02009797A (es) 2004-09-13
DE60103865T2 (de) 2004-10-28
ZA200207508B (en) 2003-09-19
ATE269057T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
HRP20021009B1 (en) Method for preparing a composition
WO2002043702A3 (en) Pharmaceutical compositions for inhalation
DK0762896T3 (da) Tocopherol-sammensætninger til levering af biologisk aktive stoffer
EP2298279A3 (en) Pharmaceutical compositions for inhalation
IS2156B (is) Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
ATE366104T1 (de) Verfahren zur herstellung von in der mundhöhle rasch zerfallenden tabletten
DK0737064T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer af hydrofobe stoffer
MXPA05013278A (es) Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
DK0994710T4 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin
DK0973506T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
WO2004041202A3 (en) Analysis of pharmaceutical solubility and stability
BRPI0309651A2 (pt) método para prevenir ou reduzir a resistência a um pesticida de uma peste de substrato, composição de pesticida, uso dos mesmos, e, método para preparar uma composição de pesticida
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
EP0856512A3 (en) 1-deoxy paclitaxels, method of preparation and pharmaceutical use
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
ATE468842T1 (de) Verfahren und zusammensetzung zur erhöhung der absorption und der bioverfügbarkeit von hydrophoben wirkstoffen im magen-darmtrakt
WO2003041656A3 (en) Soluble drug extended release system
FR2803848B1 (fr) Nouveaux derives de benzenesulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE50211212D1 (de) Pharmazeutische zubereitung enthaltend wirkstoffe aus den pflanzen centella asiatica, mahonia aquifolium und viola tricolor
HRP20000781B1 (en) Effervescent preparations
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung